In California, a new report “Analysis of Biomedical Textiles Market in U.S.” from Frost & Sullivan’s Visionary Science Team predicts a growth in the use of biomaterials, especially those that biodegrade, in medical device implants. The report notes that with an increasing geriatric population who are more likely to have chronic illnesses and longer recovery times, this is a huge step forward as they will now be less likely to need a second surgery to remove implants. The increases in demand for biodegradable implants are leading to more market innovation and new product launches to improve upon existing technologies and biomaterial applications. Some companies that are leading this work right now to keep an eye on include Boston Scientific, CR Bard, Smith and Nephew, Medtronic and Edwards Lifesciences.
Latest article
Fit for a King: Withdrawn British banknotes converted into furniture
In the United Kingdom, designer Saskia Boersma, the Surface Matter collective, and the material studio Plasticiet have transformed £2.5 million (US$3.5 million) worth of withdrawn British banknotes...
Under Armour and UNLESS launch three plant-based sneakers
In Milan, popular athleisure brand Under Armour has partnered with UNLESS, a company known for producing completely renewable garments, to market three completely plant-based...
Solar Foods creates mayonnaise (mostly) from thin air
In Finland, Solar Foods has filed a patent application for a mayonnaise formulation made using its Solein protein, which is produced by a microbe...